C004
אקס טי אל ביופרמסוטיקלס בע"מ
2
Public
X T L BIOPHARMACEUTICALS LTD
4312
Corporation no:
520039470
Stock Exchange/Market:
אקס טי אל
1996
352
Hasapir
3
,
Nes Ziona
76100
,
,
Tel:
08-9304444
,
Fax:
08-9304445
E.mail address:
rcohen@xtlbio.com
Date of transmission:
18/07/2005
Time of broadcast:
10:57
10:56:36
Reference:
2005-02-054570
Israel Securities Authority
Tel Aviv Stock Exchange
www.isa.gov.il
www.tase.co.il
Immediate report on other matter
Don't use this form if there is more adequate one
XTLbio Receives Fast Track Designation for Hepatitis C Therapy from US FDA
Attached file
PRESS.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous name of reporting entity:
XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure:
11/07/2005
Name of the Signatory
:
Burgin Jonathan
,
,
Position of Signatory in the reporting corporation:
Chief Financial Officer
Hasapir
Telephone:
08-9304440
,
Facsimile:
08-9300659
,
E-mail:
jburgin@xtlbio.com